International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Join us for a lecture on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Roger S. Klein, MD, FACP, will highlight the latest in diagnostic technologies and treatment approaches for IBD. He also will discuss the importance of comprehensive care to help prevent IBD-associated health problems.
Join us for a lecture on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Roger S. Klein, MD, FACP, will highlight the latest in diagnostic technologies and treatment approaches for IBD. He also will discuss the importance of comprehensive care to help prevent IBD-associated health problems.
This presentation was developed by expert faculty of the Crohn’s & Colitis Foundation’s Professional Education Committee. Use this resource to teach fellows or other healthcare professionals about general aspects of inflammatory bowel disease (IBD).
Inflammatory bowel disease (IBD) is a group of disorders that cause chronic inflammation (pain and swelling) in the intestines. IBD includes Crohn's disease and ulcerative colitis. Both types affect the digestive system. Treatments can help manage this lifelong condition
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...Grupo De Apoyo EII
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla?
Forma parte del taller del Grupo De Apoyo De Enfermedades Inflamatorias Del Intestino. Para mas informacion visita: www.grupodeapoyoeii.org
This presentation was developed by expert faculty of the Crohn’s & Colitis Foundation’s Professional Education Committee. Use this resource to teach fellows or other healthcare professionals about general aspects of inflammatory bowel disease (IBD).
Inflammatory bowel disease (IBD) is a group of disorders that cause chronic inflammation (pain and swelling) in the intestines. IBD includes Crohn's disease and ulcerative colitis. Both types affect the digestive system. Treatments can help manage this lifelong condition
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...Grupo De Apoyo EII
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla?
Forma parte del taller del Grupo De Apoyo De Enfermedades Inflamatorias Del Intestino. Para mas informacion visita: www.grupodeapoyoeii.org
Gall stone ileus is complication of cholithiasis. It is rare and seen in aged patients diagnosed as
cholelithiasis with co morbidities. High index of suspicion is necessary for arriving at a clinical diagnosis.
Contrast enhanced computed tomography is diagnostic. Enterolithotomy followed by closure of the fistula
with cholecystectomy as a two staged procedure is the safest approach for managing gall stone ileus.
A quick review of the various benign pathologic conditions of Gallbladder,intended primarily for the Undergraduate students; Based on Bailey & Love's Short Practise of Surgery latest edition.
Acute cholecystitis:Severity assessment and managementKETAN VAGHOLKAR
Acute cholecystitis is one of the commonest biliary tract emergency. Early diagnosis and prompt treatment is essential to reduce the morbidity and mortality associated with the disease. Assessment of the severity of the disease is essential to develop a safe therapeutic plan for the patient. The Tokyo guidelines (TG 18/TG 13) provides a lucid system for grading the severity of acute cholecystitis. Supportive care, antibiotic therapy followed by early laparoscopic cholecystectomy is the mainstay of treatment. Fitness to undergo surgery is determined by the Charlson Comorbidity Index and the American College of Anaesthesiologist’s physical status examination. Those unfit for surgery are best treated by early biliary drainage followed by delayed cholecystectomy. The incidence of iatrogenic bile duct injury is high in severe cases. A low threshold for conversion to open cholecystectomy is essential in such cases to prevent iatrogenic biliovascular injuries. A holistic clinical approach comprising of establishing the diagnosis, grading the severity of acute cholecystitis, assessment of fitness to undergo surgery, administration of supportive care and antibiotics followed by early cholecystectomy constitutes a safe surgical approach to acute cholecystitis.
Esophagus /certified fixed orthodontic courses by Indian dental academy Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
00919248678078
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Acute Biliary tract infections, Diagnostic criteria and Treatment
1. International Journal of Pharmaceutical Science Invention
ISSN (Online): 2319 – 6718, ISSN (Print): 2319 – 670X
www.ijpsi.org Volume 3 Issue 10 ‖ October 2014 ‖ PP.58-62
www.ijpsi.org 58 | Page
Acute Biliary tract infections, Diagnostic criteria and Treatment
1
Murtaza Mustafa,2
Jayaram Menon3
,MDS. Rahman4,
MTH.
Parash,5
SC.Shimmi
1,3,4,5,
Faculty of Medicine and Health Sciences, University Malaysia Sabah,KotaKinabalu.Sabah,Malaysia.
2.
Department of Gastroenterology, Hospital Queen Elizabeth,Kota Kinabalu,Sabah,Malaysia.
ABSTRACT:Biliary tract infections, bile duct obstruction include biliary colic,choleocystitis cholangitis,and
choleolithiasis are the common health problem worldwide.Twenty-five million adults have gallstones in the
United States and 120,000 choleocystomies are performed in U.S. each year. Frequent risk factors include
advance age, female sex,pregnancy using estrogen,diabetes,obesity,impacted gallstones, tumors of biliary tree,
and bacterial and parasite infection. Women have twice to three times risk of developing gallstones than men,
and whites have twice the prevalence of blacks,and Latina women showed higher prevalence than whites
Intestinal flora are the frequent cause of acute cholecystitis and acute cholangitis.Severity of acute
choleocystitis is classified into mild,grade I,moderate ,gradeII,and severe gradeIII.Diagnosis include clinical
presentation,ultrasonography,CTscan,MRIscholangiography,endoscopic retrograde
cholangiopancreatography- ERCP and, hepato-iminiodiacetic acid- HIDA test.Tokyo guidelines for the
management of acute cholangitis are heplful.Drugs of choice are the broad spectrum antibiotics such as
cefazolin,ceftriaxone,and pipercillin/tazobactam, mainly to cover enteric and anaerobic organisms.Early
diagnosis of acute cholecystitis can prevent morbidity and mortality.
KEYWORDS:Cholecystitis, Cholangitis,Diagnostic criteria,and Treatment.
I. INTRODUCTION
Infections of the biliary tract, including the common bile duct and gallbladder, are most often
associated with obstruction to the flow of bile. In the United States and many developed countries, gallstones are
very common and most often asymptomatic. In the United States, for example, it is estimated that 25 million
adults have gallstones [1].In a small percentage of cases; gallstones may obstruct the cystic or common bile
ducts, resulting in inflammation. Approximately 120,000 choleocystomies are performed every year in the
United States for acute choleocystitis,most commonly secondary to impacted gallstones(cholelithiasis)[2] Other
causes of biliary obstruction include tumors of the biliary tree or adjacent structures, strictures secondary to
surgery or other injury(including prior infection),and in may geographic areas, infection by parasites including
Ascaris and Clonorchitis.Stasis of bile, inflammation, and loss of mechanical barriers can lead to bacterial
infection of the bile, which can result in severe morbidity and death[3]Women have two to three times the
prevalence of gallstones compared with men, and whites have twice the prevalence of blacks. Latina women
showed a higher prevalence than whites, blacks or Asians. Black women did not have a significantly higher
prevalence than the white sample, other factors that appear related to the incidence of gallstones
include,obesity,parity,using estrogens and diabetes mellitus[4].Mustafa I,et al. reported 12 cases of acute
acalculous choleocystitis(AAC) in children[5].The severity of acute choleocystitis is classified into three grades
mild(grade I),moderate (grade II),and severe(gradeIII),Grade III(severe acute choleocystitis) is defined as acute
cholecystitis with organ failure[6].Enteric organisms are the frequent cause of acute choleocystitis and acute
cholangitis, with monomicrobial(76%) and polymicobial(24%),with anaerobes included[7].Diagnostics tests
include plain roentgenograms,ultrasonography,sonographic deigns,CTscan,MRIscholangiography(endoscopic
retrograde cholangiopancreatography-ERCP),HIDA(hepato-iminodiacetic acid) a functional scan test, whereas
ultrasonography is an anatomic test[8,9].Empiric antibiotic regimens are aimed primarily at gram-negative
bacteria.Cefazolin,ceftriaxone, and pipercillin/tazobactam are equally effective. In elderly or critically ill patient
and the patient with prior common duct or complex biliary procedures, a therapeutic regimen that includes
anaerobic activity is reasonable [7].Cholecystectomy remains the treatment of choice for acute choleocystitis
[8].The paper reviews the diagnostic criteria, and management of acute biliary infections.
II. PATHOPHYSIOLOGY
In choleocystitis only 20% of patients with gallstones experience biliary colic typified by right upper
quadrant pain after a fatty meal when the contracting of gallbladder is prevented from emptying by obstructing
stone. Biliary colic must be distinguished from the more serious acute choleocystitis which occurs in 1% to 3%
of persons with symptomatic gallstones. In this disease, biliary obstruction is accompanied by an intense
2. Acute Biliary tract infections…
www.ijpsi.org 59 | Page
inflammatory reaction. Obstruction is thought to lead to increased intraluminal pressure, may lead to
compromised blood supply and lymphatic drainage; and in the setting of supersaturated bile, leads to acute
inflammation.This process is mediated, at least in part, by prostaglandins, particularly postglandins,I2 and
E2[10].Infection is not thought to precipitate acute choleocystitis, but it may complicate 20% to 50% of cases. In
a microbiologic study of biliary tract processes,24(46%) of 52 patients presenting with acute choleocystitis had
positive bile cultures, compared with 0 of 42 of normal controls and 49(22%) of 221 patients with symptomatic
gallstones but no evidence of acute choleocystitis[11].Untreated choleocystitis may abate spontaneously, but
serious complications also occur at a high rate. Once infection is established complications include gangrenous
choleocystis emphysematous cholecystitis,gallbladder empyema, pyogenic liver abscess, and bacteremia.In
acalculous choleocystitis 2% to 15% of cases,choleocystitis occurs in the absence of gallstones, although usually
in the presence of other predisposing conditions. These include critical illnesses such as truma,burns and
sepsis,as well as human immunodeficiency virus (HIV)infection, immunosuppression,diabetes,nonbiliary
surgery, and childbirth[12].Some of these conditions predispose to ischemia in the gallbladder wall or stasis of
bile(or both),resulting in concentration of bile salts and leading to inflammation and necrosis of the
gallbladder[3].
Cholangitis refers to inflammation or infection of the common bile duct. The normally sterile bile may
become infected because of loss of protective factors, including the flow of bile. Obstruction of the common bile
duct leafs to stasis, which favors the growth of bacteria; increased pressure predisposes to bacteremia [3].Other
factors may involve the antibacterial activity of bile on the proximal small intestine, allowing the greater growth
of bacteria. Bacteria may then ascend to biliary tract(hence the terms ascending and suppurative
cholangitis).Other routes of infection have been proposed, including via the portal system or the
lymphatics.Primary sclerosing cholangitis is a disease of immunologic origin. AIDS related cholangiopathy,
which has many features of acute cholangitis [3].
III. INFECTING MICROFLORA
Bacterial cultures from the bile and surgical sites of patients’ acute chleocystitis and acute chlolangitis
typically yield constituents of the normal intestinal flora [13].These include gram-negative bacilli such as
E.coli,Klebsiellaspp.,Enterobacter spp.Anaerobes,most frequently Bacterioides spp.Fusobacterium spp.,and
clostridia are recovered less frequently but are isolated more often from patients with prior biliary tract surgical
procedures and those with biliary-intestinal anastomoses. Finally, enterococci are not commonly found in
infected bile, usually in association with other organisms[14].Parasites that infect the biliary tree include
clonorchis sinensis,0pisthrochis felineus,0pisthrochis viverrini,and Fasicola hepatica[15].These organisms are
prevalent in the regions of Asia and can cause acute and relapsing cholangitis with associated stricture and stone
formation. Clonorchis and 0pisthrochis infection can lead to the development of carcinoma of the biliary tract.
Ascaris lumbricoides,a more common cosmopolitan parasite, occasionally obstructs the biliary tree, resulting in
acute cholangitis[16].Echinococcal disease can cause biliary obstruction due to mass effect. Parasites that
complicate HIV disease may also invade biliary tree [3].
AIDS cholangiopathy
Biliary tract disease is a complication of advanced HIV infection. In the era of potent antiretroviral
therapy, AIDS cholangiopathy is now a rare entity [17,18].Although it is possible this condition is caused by
infection of the biliary tract with HIV per se,more likely results from opportunistic infection of the biliary
system. The pathologic findings of AIDS cholangiopathy include stenosis of the distal common duct and
irregularities of the intrahepatic and extrahepatic bile ducts[19].The most common pathogen associated with
cholangitis in HIV is Cryptosporidium .After an outbreak of cryptosporidiosis in Milwaukee in 1995,29% of
patients with HIV infection and intestinal cryptosporidiosis developed cholangiopathy as well[20].
Cytomegalovirus is also a major cause of AIDS cholangiopathy include Enterocytozoon bieneusi,Isospora
belli,and Mycobacterium aviumintracellulare.The clinical manifestations of biliary tract disease do not differ
markedly from those non-HIV-infected individuals and include right upper quadrant pain fever. Diagnosis is
usually made by characteristic finding on ultrasound, with dilatation of the common bile duct observed in
approximately two thirds of cases. Endoscopic retrograde cholangiopancreatography (ERCP) demonstrates
dilation and irregularities of the ducts and has become the gold standard for diagnosis [21].It is also useful in
treatment: Sphincterotomy provides symptomatic benefits for many patients [3].
IV. CLINICAL MANIFESTAION
Patients with biliary tract disease most often present with pain in the right upper quadrant of the
abdomen, although occasionally localizing findings are absent. The pain may radiate to the infrascapular
region.Chleocystitis and cholangitis are distinguished from simple biliary colic by the continuous nature of the
3. Acute Biliary tract infections…
www.ijpsi.org 60 | Page
pain [3].The finding of tenderness in the right upper quadrant on physical examination and the presence of
Murphy’s sign (inhibition of inspiration by pain when the area of the gallbladder fossa is palpated), with or
without a mass, are highly suggestive of biliary tract disease. Fever and tachycardia are frequent findings [3].
Complications of acute choleocystitis, which occur in 10% to 15% of cases, include hepatic or intra-abdominal
abscess, necrosis or gangrene of gallbladder, and perforation, which in turn leads to sepsis and peritonitis [3].
Acalculous choleocystitis,paerticularly in critical ill patient who is unresponsive, may produce very subtle
findings, such as unexplained fever or vague abdominal pain. A high index of suspicion is required, because
serious complications such as gangrenous gallbladder and perforation frequently occur [22].
Acute or ascending cholangitis is suggested by Charcot’s triad of right upper quadrant or epigastric abdominal
pain, fever or chills (or both), and jaundice, reported in 50% to 70% of patients [23].The additional less frequent
signs of hypotension and altered mental status, in combination with Charcot’s triad, constitute Reynold’s
pentad, which is reportedly seen in fewer than 14% of patients with ascending cholangitis. Symptoms and signs
of an inflammatory response usually are present and are reflected in the presence of fever, leukocytosis, and
other markers [24].
V. DIAGNOSTIC WORKUP
All patients require CBC,an elevated leukocytosis a left shift is the most frequent laboratory
abnormality in acute cholepcystitis.Alkaline phosphatase and bilirubin are not usually elevated unless the
common bile duct in involved. However, in one study of 217 patients with acute cholepcystitis,25% of patients
without obstruction of common bile duct had elevated bilirubin[22].The role of bile and blood cultures in the
diagnosis of cholecystitis is not well established. Recently developed practice guidelines(the “Tokyo
Guidelines”)advocate culturing blood(although Infectious Disease Society of America[IDSA} guidelines state
that blood culture are not often useful)and when obtained,bile,since positive cultures may be predictive of
progression to severe choleocystitis[25].Conversely guidelines of the IDSA recommend against collecting blood
cultures from patients with community-acquired intra-abdominal infections[26].Tokyo Guidelines for the
management of acute cholangitis and choleocystitis were published in 2007 (TG07).The severity of cholecystitis
is classified into three grades. Grade 1(mild acute choleocystitis) is defined as acute choleocystitis in a patient
with no organ dysfunction and limited disease in the gallbladder, making cholecystectomy a low- risk
procedure. Grade 11(moderate acute cholecystitis) is associated with no organ dysfunction but there is extensive
disease in the gallbladder, resulting in difficulty in safety in performing a cholecystectomy. Grade 11 disease is
usually characterized by an elevated white cell count; disease duration of more than 72h; and imaging studies
indicating significant inflammatory changes in the gallbladder. Grade 111(severe acute choelocystitis) is defined
as acute choleocystitis with organ dysfunction [6].Acute cholangitis results in presentation with the clinical
findings mentioned above. Abnormalities suggestive of sepsis syndrome, including leukocytosis, are frequently
observed. Additional laboratory abnormalities include cholestatic liver function tests with elevation in alkaline
phosphatase and bilirubin, particularly conjugated bilirubinElevation in ɣ-glutamyl transpeptidase is often seen
as well. Abnormal amylase may suggest an associated pancreatitis and elevation in transaminases may indicate
associated inflammation in liver parenchyma (or both).As in acute choleocystitis,the Tokyo guidelines
recommend obtaining aerobic and anaerobic cultures of bile aspirates and blood in cases of cholangitis/Bile
cultures are positive in 50% to 95% of patients, and blood cultures are positive in 30% to 40%[27].
Tokyo Guidelines (TG07) has been widely cited in the world literature. Because of new information
that has been published since 2007.Tokyo Guidelines revision committee conducted and analyzed a multicenter
analysis to develop the updated Tokyo Guidelines (TG13)[28].The major changes in diagnostic criteria of TG07
were re-arrangement of the diagnostic items and exclusion of abnormal pain from the diagnostic list. The
sensitivity improved from 82.8%(TG07) to 91.8%(TG13).While the specificity was similar to TG07,the false
positive rate in cases of acute choleocystitis was reduced from 15,5% to 5.9%.The sensitivity of Charcot’s triad
was only 26.4% but the specificity was 95.6%.However, the false positive rate in cases of acute choleocystitis
was 11.9% and not negligible. As for severity grading 11(moderate) acute cholangitis is defined as being
associated with any two of the significant prognostic factors which were derived from evidence presented
recently in the literature. The factor chosen allow severity assessment to be performed soon after diagnosis of
acute cholangitis.TG13 present a new standard for diagnosis, severity grading, and management of acute
cholangitis[28].
Ultrasonography findings
Ultrasonography can frequently establish the diagnosis of choleocystitis and is usually the first study
obtained. A sonographic Murphy’s sign (i.e,,pain when the ultrasound transducer probes the gall bladder)is a
useful diagnostic clue. In addition, the testing may be done at the bedside of critically ill patients, is relatively
inexpensive and can directly visualize stones, particularly in the gallbladder. Abnormalities such as gallbladder
wall thickening of greater than 4 mm,pericholecystic fluid, and intramural gas or ductal dilation are suggestive
4. Acute Biliary tract infections…
www.ijpsi.org 61 | Page
of choleocystitis.[2].The combination of stones and either wall thickening or a sonographic Murphy’s sign in the
appropriate clinical picture were shown to have positive and negative predictive values exceeding 90%[29].
Radionuclide cholescintigraphy(hepato-iminodiacetic acid [HIDA} scanning) may be used if ultrasound fails to
ascertain a diagnosis. A technetium 99m(99m
Tc)-labeled derivative of acetanilide iminodiacetic acid is injected
intravenously and excreted into the bile. It is taken up by the gallbladder, which can then be visualized. Failure
of the gallbladder to accumulate the marker is highly suggestive of choleocystitis due to obstruction of the cystic
duct. Normally, visualization of the common bile duct and small bowel occurs, within 30 to 60 minutes; failure
to visualize these structures indicates obstruction within the common bile duct or at ampula.In one study of
cholescintigraphy in the diagnosis of acalculous choleocystitis in 62 critically ill patients, ultrasonography had
sensitivity of only 30% whereas HIDA scanning had sensitivity of 100% and specificity 88%[30].
CT is not commonly used for the clinical evaluation of choleocystitis and its sensitivity and specificity for
detection of this condition are not known. CT finding associated with acute choleocystitis include gallstones,
particularly within the cystic duct, gallbladder distention and mural thickening, and enhancement of the liver
adjacent to the gallbladder, which is CT equivalent of the scintigraphic“rim sign”[31].Magnetic
resonance(MR)cholangiography is noninvasive technique that has been used to visualize the bile ducts. In one
study of 35 patients comparing ultrasonography with MR cholangiography, the later modality showed 100
sensitivity for the presence of stones but was less sensitive than ultrasound in the detection of gallbladder wall
thickening (69% vs.96%)[32].In a meta- analysis of 67 studies of MR cholangiography, the technique was
highly sensitive-99%- for the detection of biliary obstruction and 92% sensitive for the detection of stones[33].
VI. TREATMENT
The biliary disease results most commonly from obstruction of the bile ducts, definitive treatment
involves removal of the obstruction or the infected material. This can be accomplished surgically,
percutaneously or endoscopically(i.e.,by ERCP).Antibiotics and other supporting measures must be considered
temporizing[2].The role of antibiotics in acute choleocystitis has not been well established. Studies of patients
with uncomplicated choleocystitis have failed to demonstrate a reduction in complications such as percholic
abscess or perforation with antibiotic administration [34].Indeed; many cases of acute choleocystitis remit
spontaneously. Antibiotics are clearly indicated for patients with complications of choleocystitis such as
emphysematous or gangrenous cholecystitis or perforation.Antibiotics directed against enteric flora, should be
given to patients who are debilitated, severelyill,elderly, immunocompromised or jaundiced. A β-lactam-β-
lactamase inhibitor combination such as ampicillin/sulbactam or piperacillin/tazobactam is reasonable empirical
therapy for community acquired choleocystitis,depending on local susceptibility pattern[34].Alternatively, a
third- or fourth generation cephalosporin’s may be used despite the lack of activity against enterococci [26].In
one study, a cephalosporins (cefpime) was as effective as a combinations that covered enterococci(mezocillin
and gentamicin),despite the presence of enterococci in bile cultures of 6 of 56 cefepime-treated patients[14].This
finding may be the result of the low pathogenic potential of enterococci in this setting, elimination of other
pathogens effectively treats the infection even in setting of persistent enterococcal contamination. As
enterococci resistance to many antibiotics increases, the difficulty in directing therapy to these pathogens makes
attempts at empirical coverage more difficult [26].
Acute cholangitis remains a disease with substantial mortality, and therapy should include antibiotics
and supportive measures along with decompression/drainage of the biliary system for cases that do not respond
promptly to conservative therapy. A variety of antibiotic regimens have been used in the management of acute
cholangitis[24].Empirical coverage should be directed against enteric gram-negative bacilli. A β-lactam/β-
lactamaseInhibitor such as ampicillin/sulbactam,ticarcillin/calvunate or piperacillin/tazobactam is appropriate
initial empirical therapy[27].Cephalosprins,carbapenems,and fluroquinolones have also proved efficacious[27].
Selection of empirical antibiotic therapy in cases of health care- associated disease be influenced by local
nosocomial resistance patterns as well as the patient’s prior antibiotic exposures and known microbial
colonization in acute cholangitis, the addition of metronidazole to the non β lactamβ-lactamase inhibitor
combination and noncarbapenem regimens is advisable[27].Drainage of the biliary tract may be accomplished
surgically, endoscopically,or percutaneously.ERCP has, to a large extent supplanted open surgical procedures in
the management of acute cholangitis and is successful in more than 90% of cases[35].Paradoxically,ERCP is not
infrequently the cause of acute cholangitis when it is used in an attempt to decompress and obstructed but not
frankly infected bile duct[36]ERCP is generally thought to have a lower morbidity rate than open surgery, and it
is more likely to offer definitive treatment(e.g.,by removal of an impacted gallstone) than percutaneous biliary
drainage[3].
5. Acute Biliary tract infections…
www.ijpsi.org 62 | Page
VII. CONCLUSION
Delay in diagnosis of acute choleocystitis increases morbidity and mortality.ERCP has supplanted open
surgical procedures. Tokyo guidelines (TG13) present a new standard for the diagnosis, severity grading, and
management of cholangitis.
REFERENCES
[1]. Everhar JE,Khare M, Hill M,et al.Prevalence and ethnic differences in gallstone disease in the United
States.Gastroenteriology.1999;117:632-39.
[2]. Strasberg SM.Clinical practice:Acute calculous cholecystitis.N Engl JMed. 2008;358:2804-11.
[3]. Sifri CD..Madoff LC.Infections of the liver and Biliary System.In:Mandell.Douglas andBennett’s Principles and Practice of
Infectious Diseases,7th ed,Mandell GI,Bennett Je,Dolin R(editors).Churchill Livingstone Elsevier,2010.
[4]. Arevaldo JA,Wolkitzer A0,Corporon MB,et al.Ethnic variability in cholethiasis-An autopsy study. West J Med.1987;147:44-47.
[5]. Mustafa I,Sarahan H,Sari A,et al.Acute acalculous choleocystitis in children: Diagnosis and treatment.J Pedtrc surg.2002;37:36-
38.
[6]. Hirota M,Takada T,Kawarada Y,et al.Diagnostic criteria and severity assessment of acute choleocystitis:Tokyo Guidelines.J
Hepatbiliary Pancreat surg.2007;14:78-82.
[7]. Brook I.Aerobic and anaerobic microbiology of biliary tract disease Microbiol.1989;27:2373.
[8]. Roslyn JJ,Zinner MJ.Gallbladder and extrahepatic biliary system.In:Schwartz SI,et al.Principles of Surgery,6th
ed.New
York:MacGraw- Hill,1994:1367
[9]. Marton KI,Doubilet P.How to image the gallbladder in suspected choleocystitis.AnnIntern Med.1988;109:722.
[10]. Indar AA,Bekingham JJ.Acute cholecystitis.BMJ.2002;325:639-43.
[11]. Csendes A,Burdiles P.Maluenda F,et al.subcuteneous bacteriologic assessment of bile from gallbladder and common bile duct in
control subjects and patients with gallstones and common duct stones. Arch surg.1996;131:389-94.
[12]. Shipro Mj,Lachtefeld WB,Kurzweil S,et al.Acute acalculous cholecystitis in the critically ill..Ann surg.1994;60:335-39.
[13]. Marne C,Pallares R,et al.Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile.Eur J Clin
Microbiol.1986;5:35-39.
[14]. Yellin AE,Berne Tv,Appleman MD,et al.A randomized study of cefpime versus the combination of gentamicin and mezlocillin
as an adjunct to surgical treatment in patients with acute choleocystitis.Surg Gynecol Obstet.1993;177(suppl):23-
29:discussion.35-40.
[15]. MarcosIA,Terashima A,Gotuzzo F.Update on hepatobiliary flukes fascioliasis, opishorchiasis and clononchiasis.Curr 0pin Infect
Dis.2008;21:523-30.
[16]. Sandouk F,Haffar S,Zada MM,et al.Pancreatic biliary ascariaisis Experience of 300 cases. Am J Gastroenterol.1997;92:2264-67.
[17]. Nash JA,Cohen SA.Gallbladder and biliary tract disease in AIDS.Gastroenterol ClinNorth Am.1997;26:323-35.
[18]. Ko WF,Cello JR,Rogers SJ,et al.Prognostic factors for the survival of patients with AIDs cholangiopathy.Am J
Gasteroenterol.2003;98:2176-2181.
[19]. Margulis SJ,Honig CJ,Soave R,et al.Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern
Med.1986;105:207-10.
[20]. Valci NB,Schwartz SM,Buggy BP,et al.Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of
cryptosporidiosis in Milwaukee.N.Engl JMed.1996;334:19-23.
[21]. Ducreux M,Buffet C,Lamy P,et al.Diagnosis and prognosis of AIDS-related cholangitis.AIDS.1995;9:875-80.
[22]. Kurzweil SM,Shapiro MJ,Andrus CH,et al.Hyperbilirubinia without common bile duct abnormalities and hyperamylamia
without pancreatitis in patients with gallbladder disease..Arch Surg.1994;129:829-23.
[23]. Wada K,Takada T,Kawarada Y,et al.Diagnostic criteria and severity assessment of cholangitis:Tokyo Guidelines.J Hepatibiliary
Pancreat Surg.2007;14:52-58.
[24]. Hanau IH,Steigbigel NH.Acute (ascending) cholangitis.Infect Dis Clin NorthAm. 2000;14:521-46.
[25]. Yoshida M,Takada T,Kawarada Y,et al.Antimicrobial therapy for acute choleocystitis. Tokyo Guidelines.J Hepsatbiliary
Pancreat Surg.2007.14:83-90.
[26]. Solomkin JS,Marzuski JE,Baron EJ,et al.Guidelines for the selection of anti-infective agents for complicated intraabdominal
infections.Clin Infect Dis.2003;37:997-1005.
[27]. Tanaka A,Takada T,Kawarada Y,et al.Antimicrobial therapy for acute cholangitis: Tokoyo Guidelines.J Hepatobiliary Pancreat
Surg.2007;14:59-67.
[28]. Kiriyama S,Takada T,Strasberg SM,et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo
Guidelines.J HepatobiliaryPancreat Sci.2012;19(5):548-56.
[29]. Ralls PW,Colleti PM,Lapin SA,et al.Real-time sonography in suspected acute choleocystitis Prospective evaluation of primary
and secondary signs. Radiology. 1985;155:767-771.
[30]. Puc MM,Tran HS,Wry PW,et al.Ultrasound is not useful screening tool for acute acalculous choleocystitis in critically ill trauma
patients.Am Surg.2002;68:65-69.
[31]. Bennet Gl,Rusinek H,Lisi V,et al.CT findings in acute gangrenous choleocystitis.AJRAm J Roentgenol.2002;178:275-81.
[32]. Park MS, Yu JS,Kim YH,et al. Acute choleocystitis comparison of MR cholangiography and US.Radiology.1998;209:781-85.
[33]. RomagnuoloJ,BandouM,RahmeF,etal.Magneticresonance cholangiopancreatography :A meta- analysis of test performance in
suspected biliary disease. Ann Intern Med.2003;139:547-57
[34]. Kune GA, Burdon JG,Are antibiotic necessary in acute choleocystitis?.Med JAust.1975;2:627-30.
[35]. Lai BC, Mok FP, Tan ES,et al.Endoscopic biliary drainage for severe acute cholangitis.N Engl J Med.1992;326:1582-86.
[36]. DeviereJ,Motte S,Dumonceau JM,et al.Septicemia after endoscopic retrograde
cholangiopancreatography.Endoscope.1990;22:72-75.